Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control is Inadequate on Dulaglutide

Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."

Dr. Centor discusses currently available evidence about high-concentration cannabis products and mental health outcomes with Drs. Paula Riggs and Jonathan Samet.

Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."

Dr. Centor discusses the role of ablation in the management of patients with atrial fibrillation with Dr. Peter Zimetbaum.

Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.

Dr. Centor discusses outcomes in patients with inadequately controlled type 2 diabetes when the dulaglutide dose is escalated versus switching to tirzepatide.

Dr. Centor discusses the diagnosis of primary aldosteronism with Dr. Jordana Cohen.

Dr. Centor discusses artificial intelligence-assisted urgent care with Dr. Zehavi Kugler.

Dr. Centor discusses pseudogout with Dr. Robert McLean.

Dr. Centor discusses the effectiveness and safety of glucagon-like peptide-1 receptor agonists for weight loss in the absence of diabetes with Ms. Areesha Moiz.